| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormalities in retinoic acid receptor beta (RAR-β) are common in human lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 199-
1 p.
|
artikel
|
| 2 |
A novel membrane protein induced during commitment stage of squamous differentiation in normal human bronchial epithelial cells
|
|
|
1990
|
6 |
5-6 |
p. 205-
1 p.
|
artikel
|
| 3 |
Antibiotic prophylaxis in lung cancer surgery
|
Ratto, Giovanni B.
|
|
1990
|
6 |
5-6 |
p. 184-191
8 p.
|
artikel
|
| 4 |
Antibodies to lung cancer antigens: Potentially useful reagents for diagnosis, imaging and therapy
|
|
|
1990
|
6 |
5-6 |
p. 201-
1 p.
|
artikel
|
| 5 |
A phase II trial of PFL in advanced NSCLC
|
|
|
1990
|
6 |
5-6 |
p. 204-
1 p.
|
artikel
|
| 6 |
A pilot study of cisplatinum and etoposide (CE) plus concomitant radiation (RAD) as adjuvant therapy in non small cell lung cancer (NSCL)
|
|
|
1990
|
6 |
5-6 |
p. 203-
1 p.
|
artikel
|
| 7 |
Binding of neuroendocrine markers and biotinylated sex hormones and the survival in human lung cancer
|
Kayser, K.
|
|
1990
|
6 |
5-6 |
p. 171-183
13 p.
|
artikel
|
| 8 |
Biology of drug resistance in lung cancer
|
Bernal, Samuel D.
|
|
1990
|
6 |
5-6 |
p. 196-197
2 p.
|
artikel
|
| 9 |
Biomarkers of small cell lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 202-
1 p.
|
artikel
|
| 10 |
Characterization of a gene associated with proliferation-arrested rat alveolar type 2 cells
|
|
|
1990
|
6 |
5-6 |
p. 206-
1 p.
|
artikel
|
| 11 |
Chemosensitivity of transplantable non-small cell bronchial rat tumours growing subcutaneously or in the lung
|
|
|
1990
|
6 |
5-6 |
p. 201-
1 p.
|
artikel
|
| 12 |
Chemotherapy in small cell lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 207-
1 p.
|
artikel
|
| 13 |
Cisplatin based chemotherapy with accelerated, B.I.D. radiation therapy for advanced non-small cell lung cancer (NSCLC)
|
|
|
1990
|
6 |
5-6 |
p. 205-
1 p.
|
artikel
|
| 14 |
Clinical trials of edatrexate: An antifolate with activity in non-small cell lung cancer (NSCLC)
|
|
|
1990
|
6 |
5-6 |
p. 203-
1 p.
|
artikel
|
| 15 |
Combination immunochemotherapy in patients with lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 205-
1 p.
|
artikel
|
| 16 |
Considerations in population based screening for the early detection of lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 201-
1 p.
|
artikel
|
| 17 |
Controversies in the treatment of non small cell lung cancer with radiotherapy
|
|
|
1990
|
6 |
5-6 |
p. 197-
1 p.
|
artikel
|
| 18 |
Controversies in the treatment of SCLC
|
|
|
1990
|
6 |
5-6 |
p. 207-
1 p.
|
artikel
|
| 19 |
Detailed epitope mapping of lung cancer associated carbohydrate antigens detected by antibodies obtained from various laboratories
|
|
|
1990
|
6 |
5-6 |
p. 198-199
2 p.
|
artikel
|
| 20 |
Epithelial antigen expression and drug-sensitivity in lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 206-
1 p.
|
artikel
|
| 21 |
Ethical problems in clinical research in non-small cell lung cancer. The expert surrogate studies
|
Mackillop, William J.
|
|
1990
|
6 |
5-6 |
p. 147-158
12 p.
|
artikel
|
| 22 |
Expression of the protein kinase P-68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms
|
|
|
1990
|
6 |
5-6 |
p. 199-
1 p.
|
artikel
|
| 23 |
Extracellular matrix in preneoplastic lesions and early cancer of the lung
|
|
|
1990
|
6 |
5-6 |
p. 199-
1 p.
|
artikel
|
| 24 |
Functional expression of specific subsets of enhancer binding proteins associated with the differentiation state of lung carcinomas
|
Wong, Yuk-Chor
|
|
1990
|
6 |
5-6 |
p. 199-
1 p.
|
artikel
|
| 25 |
Growth factors in non-small cell lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 200-
1 p.
|
artikel
|
| 26 |
High local recurrence and brain metastases in non-small cell lung cancer (NSCLC) treated with chemo-radiotherapy
|
|
|
1990
|
6 |
5-6 |
p. 205-
1 p.
|
artikel
|
| 27 |
Immunotoxins for small cell lung cancer: Results of in vitro investigations
|
|
|
1990
|
6 |
5-6 |
p. 198-
1 p.
|
artikel
|
| 28 |
Induction of non-small cell lung cancer (NSCLC) phenotypic features by oncogenic transformation of small cell lung cancer (SCLC) cells
|
|
|
1990
|
6 |
5-6 |
p. 200-
1 p.
|
artikel
|
| 29 |
Intensive multimodality therapy for small cell lung cancer (SCLC) using intensification with high dose chemotherapy and autologous bone marrow support
|
|
|
1990
|
6 |
5-6 |
p. 204-
1 p.
|
artikel
|
| 30 |
International Conference on Lung Cancer
|
Bernal, Samuel D.
|
|
1990
|
6 |
5-6 |
p. 193-195
3 p.
|
artikel
|
| 31 |
Introduction of a mutated p53 gene alters neuroendocrine differentiation in human small cell lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 200-
1 p.
|
artikel
|
| 32 |
Less intensive chemotherapy for small cell lung carcinoma
|
|
|
1990
|
6 |
5-6 |
p. 207-
1 p.
|
artikel
|
| 33 |
Mechanisms of decreased drug transport in cells resistant to methotrexate and cisplatinum
|
Urbano, A.Godofredo
|
|
1990
|
6 |
5-6 |
p. 206-
1 p.
|
artikel
|
| 34 |
Multimodality therapy for stage III non-small cell lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 197-
1 p.
|
artikel
|
| 35 |
Neoadjuvant chemotherapy (CT) and radiotherapy (RT) followed by surgery (S) in stage IIIA non-small cell lung cancer (NSCLC): A phase II study of the cancer and leukemia group B
|
|
|
1990
|
6 |
5-6 |
p. 202-
1 p.
|
artikel
|
| 36 |
Phase I/II trial of oral ifosphamide (OI)/mesna (M) in advanced, non-small cell lung cancer (NSCLC)
|
|
|
1990
|
6 |
5-6 |
p. 203-204
2 p.
|
artikel
|
| 37 |
Phase II studies using prolonged administration of oral etoposide in the treatment of lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 203-
1 p.
|
artikel
|
| 38 |
Phase II trial of very high dose cisplatin (DDP) and etoposide (VP-16) and mitomycin-C (Mito-C) in advanced non-small cell lung cancer (NSCLC)
|
|
|
1990
|
6 |
5-6 |
p. 205-206
2 p.
|
artikel
|
| 39 |
Phenotypic consequences of genetic alterations in small cell lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 196-
1 p.
|
artikel
|
| 40 |
Rapidly alternating radiotherapy and high dose cisplatin in stage III non-small cell lung cancer (NSCLC): Results of phase I–II study
|
|
|
1990
|
6 |
5-6 |
p. 202-
1 p.
|
artikel
|
| 41 |
Recent advances in the pathological diagnosis of lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 202-
1 p.
|
artikel
|
| 42 |
Reduction in the incidence of chemotherapy-induced febrile neutropenia in patients with small cell lung cancer by granulocyte colony stimulating factor (r-metHuG-CSF)
|
|
|
1990
|
6 |
5-6 |
p. 204-
1 p.
|
artikel
|
| 43 |
Regulation of proliferation and differentiation of tracheobronchial epithelial cells
|
|
|
1990
|
6 |
5-6 |
p. 196-
1 p.
|
artikel
|
| 44 |
Regulation of proliferation-related genes in pulmonary alveolar type 2 cells
|
|
|
1990
|
6 |
5-6 |
p. 196-
1 p.
|
artikel
|
| 45 |
Reversal of preneoplastic changes in upper respiratory epithelium
|
|
|
1990
|
6 |
5-6 |
p. 197-
1 p.
|
artikel
|
| 46 |
Role of surgery in locally advanced non-small cell lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 197-
1 p.
|
artikel
|
| 47 |
Small cell lung cancer (SCLC) antigens are expressed differently on human continuous cultured cell lines representing SCLC “classic,” “variant,” and carcinoid phenotypes
|
Koros, A.M.C.
|
|
1990
|
6 |
5-6 |
p. 198-
1 p.
|
artikel
|
| 48 |
Specific targeting of lung cancer using monoclonal antibodies
|
|
|
1990
|
6 |
5-6 |
p. 201-
1 p.
|
artikel
|
| 49 |
Targeted therapy for lung cancer by isolated perfusion
|
|
|
1990
|
6 |
5-6 |
p. 207-208
2 p.
|
artikel
|
| 50 |
The human adenocarcinoma associated antigen recognized by the monoclonal antibody 44-3A6 is a transmembrane phosphoprotein
|
|
|
1990
|
6 |
5-6 |
p. 207-
1 p.
|
artikel
|
| 51 |
The role of chromosome 3 deletions in lung cancer
|
Kadowaki, Mark H.
|
|
1990
|
6 |
5-6 |
p. 165-170
6 p.
|
artikel
|
| 52 |
Treatment of disseminated non small cell lung cancer
|
|
|
1990
|
6 |
5-6 |
p. 198-
1 p.
|
artikel
|
| 53 |
Treatment of small cell carcinoma of the lung with monoclonal antibodies
|
|
|
1990
|
6 |
5-6 |
p. 200-201
2 p.
|
artikel
|
| 54 |
Urban-rural differences in lung cancer occurrence. Time trends in Jews in Israel
|
Rennert, Gad
|
|
1990
|
6 |
5-6 |
p. 159-164
6 p.
|
artikel
|
Tijdschrift beschrijving